GRAL GRAIL, Inc.

CIK 0001699031 25 ready 8-Ks latest June 1, 2026, 4:07 PM ET RSS · JSON

Ready 8-Ks 25

Latest filing June 1, 2026, 4:07 PM ET

Top materiality 0.95

Event mix other_material ×12 · earnings ×8 · leadership ×3

Sentiment 4 pos · 2 neg · 19 neu

Latest earnings reported 2026-Q1

Executive change recent →

Recent 8-K filings for GRAL

Highest-materiality recent filing

GRAIL completes spin-off from Illumina; receives $932M funding, starts trading June 25

June 24, 2024, 7:59 PM ET M&A materiality 0.95 positive item 1.01 item 3.03 item 5.03 item 5.01 item 5.02 item 9.01

Illumina distributed 85.5% of GRAIL shares to its shareholders (1 per 6 shares) on June 24, 2024; Illumina retains 14.5%.
GRAIL received ~$932.3M one-time disposal funding from Illumina; begins trading on Nasdaq under GRAL on June 25.

Read filing →

June 1, 2026, 4:07 PM ET leadership materiality 0.70 neutral item 5.02 item 8.01 item 9.01

GRAIL appoints Joshua Ofman as CEO with amended compensation and severance

Joshua Ofman appointed CEO effective June 1, 2026; annual base salary $800,000.
May 5, 2026, 7:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

GRAIL Q1 2026: revenue $40.8M (up 28%), Galleri volume 56k+ (up 50%), net loss $93.2M

Total revenue $40.8M (+28% YoY); Galleri revenue $39.8M (+37%); test volume >56,000 (+50%).
February 19, 2026, 6:59 PM ET other material materiality 0.80 neutral item 2.02 item 8.01 item 9.01

NHS-Galleri trial misses primary endpoint but shows Stage IV reduction; Q4 rev $43.6M

Primary endpoint of significant Stage III-IV reduction not met; substantial Stage IV reduction observed across 12 deadly cancers.
November 14, 2025, 6:59 PM ET other material materiality 0.60 neutral item 8.01 item 9.01

GRAIL enters $300M ATM equity distribution agreement with Morgan Stanley and TD Securities

Company may sell up to $300M of common stock (max 6.9M shares) at-the-market.
November 12, 2025, 6:59 PM ET earnings materiality 0.65 positive item 2.02 item 9.01

GRAIL Q3 revenue $36.2M (+26% YoY); U.S. Galleri revenue $32.6M (+28%)

Net loss $89.0M, improving 29% YoY; adjusted EBITDA $(71.7)M.
October 20, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 3.02 item 9.01

GRAIL raises $325M in private placement at $70.05/share; funds operations into 2030

Gross proceeds ~$325M from 4,639,543 shares/pre-funded warrants at $70.05/share.
October 16, 2025, 7:59 PM ET M&A materiality 0.85 positive item 1.01 item 2.02 item 3.02 item 7.01 item 9.01

Samsung invests $110M in GRAIL at $70.05/sh; exclusive Galleri rights in South Korea; Q3 prelim results

Samsung C&T and Samsung Electronics invest $110M in GRAIL at $70.05/share (~1.57M shares) via private placement.
September 18, 2025, 7:59 PM ET other material materiality 0.75 neutral item 1.01 item 2.03 item 9.01

GRAIL signs 11-year lease for 75,556 RSF Sunnyvale HQ; base rent ~$449,558/month

11-year lease for ~75,556 RSF office/lab at 250 S. Matilda Ave, Sunnyvale, CA.
August 12, 2025, 7:59 PM ET earnings materiality 0.60 neutral item 2.02 item 9.01

GRAIL Q2 revenue $35.5M (+11% YoY); net loss $114M includes $28M impairment

U.S. Galleri revenue $34.2M (+21% YoY); Galleri tests sold >45,000 (+29% YoY).
May 13, 2025, 7:59 PM ET earnings materiality 0.65 positive item 2.02 item 9.01

GRAIL Q1 revenue $31.8M (+19% YoY); Galleri U.S. revenue $28.7M (+22%); net loss improves

Total revenue $31.8M, up 19% YoY; U.S. Galleri revenue $28.7M, up 22% YoY.
November 12, 2024, 6:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01

GRAIL Q3 2024: Galleri revenue $25.4M (+52% YoY); net loss $(125.7)M

Total revenue $28.7M (+38% YoY); Galleri revenue $25.4M (+52% YoY).
August 13, 2024, 7:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01

GRAIL Q2 revenue up 43% to $32M; net loss $(1.59)B due to $1.42B impairment

Revenue of $32.0M (+43% YoY), driven by Galleri test sales exceeding 215,000 cumulative units.
June 27, 2024, 7:59 PM ET other material materiality 0.90 negative item 2.06

GRAIL expects $888.9M goodwill impairment & ~$420M IPR&D charge in Q2 2024

Goodwill impairment charge of $888.9 million, full remaining carrying value as of March 31, 2024.
June 24, 2024, 7:59 PM ET M&A materiality 0.95 positive item 1.01 item 3.03 item 5.03 item 5.01 item 5.02 item 9.01

GRAIL completes spin-off from Illumina; receives $932M funding, starts trading June 25

Illumina distributed 85.5% of GRAIL shares to its shareholders (1 per 6 shares) on June 24, 2024; Illumina retains 14.5%.
June 3, 2024, 7:59 PM ET other material materiality 0.60 neutral item 8.01 item 9.01

GRAIL spin-off from Illumina declared effective; distribution details set

SEC declared effective Form 10 for GRAIL spin-off on June 3, 2024.

Executive changes

Appointed

Joshua Ofman

Chief Executive Officer

GRAL · GRAIL, Inc.

Effective: 2026-06-01
Filed: June 1, 2026, 4:07 PM ET

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers In connection with Dr. Joshua Ofman’s appointment as the Chief Executive Officer of GRAIL, Inc. (the “Company”), on June 1, 2026, the Company’s board of directors (the “Board”) approved an amended and restated offer letter (the “Amended Offer Letter”) and authorized and directed the Company to enter into such Amended Offer Letter with Dr. Ofman, with the Amended Offer Letter effective as of June 1, 2026 (the “Effective Date”).

Appointed

Sarah Krevans

Director

GRAL · GRAIL, Inc.

Effective: 2024-10-21
Filed: October 22, 2024, 7:59 PM ET

On October 21, 2024, the Board of Directors (the “Board”) of GRAIL, Inc. (the “Company”) appointed Sarah Krevans to the Board, effective immediately.

Appointed

Robert Ragusa

Chief Executive Officer

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

Robert Ragusa Chief Executive Officer

Departed

Ankur Dhingra

Director

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.

Departed

William (Bill) Chase

Director

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.

Appointed

Gregory (Greg) Summe

Director

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.

Appointed

Gregory (Greg) Summe

Chair of the Board

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

Mr. Summe was appointed as the Chair of the Board

Appointed

Josh Ofman

President

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

Josh Ofman President

Appointed

Aaron Freidin

Chief Financial Officer

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

Aaron Freidin Chief Financial Officer

Appointed

Steve Mizell

Director

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.

Appointed

Robert Ragusa

Director

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.

Appointed

William (Bill) Chase

Director

GRAL · GRAIL, Inc.

Effective: 2024-06-21
Filed: June 24, 2024, 7:59 PM ET

William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.

Earnings & guidance

2026-Q1 EPS reported -$2.29 filing →

Materiality & sentiment trend

Max materiality 0.95 · Median 0.60 · Most common event other_material

4 positive 2 negative 19 neutral

source · GRAL on sec.gov